INSIGHTS ON SOLID DOSE MANUFACTURING
-
How Dosage Form Decisions Shape Pediatric And Geriatric Drug Development
Developing pediatric and geriatric pharmaceuticals requires customized strategies beyond tablet crushing, balancing specific age-related palatability, packaging, real-world administration, and lifecycle management needs for optimal patient outcomes.
-
How Patent Expirations Will Reshape The Dry Powder Inhaler (DPI) Market
Patent expirations on dry powder inhalers are driving rapid market competition. Discover how optimized mechanical dosing speeds scale-up and protects profit margins.
-
Don't Let Your Filling Equipment Dictate Your Drug Formulation
Gravimetric powder dosing measures true mass to eliminate equipment-driven reformulation, preserving particle design and speeding clinical development.
-
Inline Buffer Formulation Systems
Eliminate large storage tanks and optimize cleanroom space with automated inline buffer formulation. See how on-demand fluid handling provides precise, real-time pH and conductivity control.
-
Contract Pharma 2026: Mikart On CDMO Collaboration4/30/2026
An overview of a milestone pharmaceutical outsourcing conference focused on CDMO collaboration, tech transfer, and oral solid and liquid dose manufacturing strategies.
-
Beyond Development: Using Continuous Manufacturing To Accelerate OSD Commercialization8/31/2026
Hear firsthand insights from Douglas B. Hausner, Ph.D., Senior Manager of Continuous Manufacturing, on the company’s first OSD product submission enabled by continuous manufacturing and Real-Time Release Testing.
-
Ask Us Anything: Daniele Vigo On Cost-Effective Process Development7/23/2026
Daniele Vigo, Assistant Director at Cambrex Milan, on getting yield, purity, and scalability right without burning through the budget.
-
Enabling Flexibility And Scientific Innovation In OSD Development8/31/2026
How one clinical-stage CNS biotech navigated early formulation complexity, shifting pipeline priorities, and scalable manufacturing demands through a strategic CDMO partnership.
-
5 Hidden Risks In Early-Phase OSD Formulation Development8/31/2026
Early formulation decisions in OSD development carry risks that may not surface until later stages, when the cost of course correction is significantly higher.
SOLID DOSE MANUFACTURING SOLUTIONS
-
The DoverPac® Bag In/Bag Out (BIBO) containment system is a family of contained transfer designs for multiple processes. The primary components for this validated operation consist of multiple groove canisters, docking interface hardware, and softgoods in either continuous liner form or discreet liners.
-
Inno4Life, part of the Dec Group, has in-depth knowledge and containment equipment solutions for the aseptic/sterile Fill-Finish pharmaceutical industry. In line with ISO 14644, including monitoring of viable and non-viable monitoring to comply with the most recent revisions of the ISPE containment specifications cGMP and GAMP5 guidelines.
-
Optimize your aseptic workflows with this adaptable containment platform, featuring flexible airflow and pressure controls to ensure rigorous sterility for diverse pharmaceutical processes.
-
Dec excels in providing comprehensive technical solutions for packing powders into bags and drums from process equipment discharge such as a dryer or a mixer, milling and dispensing to the final packing of the product.
-
Isolators with product protection as a housing for aseptic processes, e.g., filling, loading and unloading of freeze dryers.